Elizabeth S. Ginsburg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elizabeth S. Ginsburg has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Stacey A. Missmer
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
2 shared publications - Alesia M. Jung
Exponent Inc. Menlo Park California USA
1 shared publication - Allison F. Vitonis
Department of Obstetrics and Gynecology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
1 shared publication Andrea Lanes
1 shared publicationAnna Greer
Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, Massachusetts
1 shared publicationCassie L. Hobbs
Division of Reproductive Endocrinology and Infertility, University of Pennsylvania, Philadelphia, Pennsylvania
1 shared publication
Latest Publications
- 28 May 2026
- Published by Elsevier in Fertility and Sterility
- Vol. 126 (2) , 263-264
The importance of cycle review meetings
- 28 May 2026
- Published by Elsevier in Fertility and Sterility
- Vol. 126 (2) , 263-264
The importance of cycle review meetings
- 5 January 2026
- Published by Elsevier in Fertility and Sterility
- Vol. 125 (2) , 228-233
Should you do ultrasound monitoring and trigger for intrauterine insemination cycles?
- 5 January 2026
- Published by Elsevier in Fertility and Sterility
- Vol. 125 (2) , 228-233
Should you do ultrasound monitoring and trigger for intrauterine insemination cycles?
- 30 December 2025
- Published by Elsevier in Fertility and Sterility
- Vol. 125 (2) , 227
To ultrasound and trigger or not in intrauterine insemination cycles, that is the question
- 30 December 2025
- Published by Elsevier in Fertility and Sterility
- Vol. 125 (2) , 227
To ultrasound and trigger or not in intrauterine insemination cycles, that is the question
- 23 August 2025
- Published by Elsevier in Fertility and Sterility
- Vol. 124 (4) , 584
A comprehensive update on the reproductive care of patients with cancer and survivors in reproductive endocrinology practice
- 23 August 2025
- Published by Elsevier in Fertility and Sterility
- Vol. 124 (4) , 584
A comprehensive update on the reproductive care of patients with cancer and survivors in reproductive endocrinology practice
- Open Access
- 17 June 2022
- Published by Elsevier in F&S Reports
- Vol. 3 (3) , 237-245
In vitro fertilization cycle and embryo transfer outcomes in oligoanovulatory patients with hypothalamic hypogonadism vs. polycystic ovary syndrome and compared with normo-ovulatory patients
- 17 June 2022
- Published by Elsevier in F&S Reports
- Vol. 3 (3) , 237-245
Open AccessIn vitro fertilization cycle and embryo transfer outcomes in oligoanovulatory patients with hypothalamic hypogonadism vs. polycystic ovary syndrome and compared with normo-ovulatory patients
- Open Access
- 12 March 2021
- Published by Springer Nature in Fertility Research and Practice
- Vol. 7 (1) , 1-13
Self-reported infertility diagnoses and treatment history approximately 20 years after fertility treatment initiation
Background: Infertility history may have important implications for clinical practice and scientific discovery. Previous research on the validity of self-reported infertility measurements has been limited in scope and duration (< 5 years). In this study, we validated self-reported infertility history measures 15–23 years after fertility treatment initiation among women who utilized assisted reproductive technology (ART). Methods: Women who received ART treatments from three Boston infertility clinics and who enrolled in a prior study (1994–2003) were re-contacted in 2018 for the AfteR Treatment Follow-up Study (ART-FS). Infertility history was collected from clinical records and two self-report questionnaires (at ART initiation and at ART-FS enrollment). Treatment history included specific details (fresh or frozen embryo transfers, number of cycles) and treatment recall prior to ART initiation. Self-reported infertility diagnoses included polycystic ovary syndrome (PCOS), endometriosis, uterine factor infertility, tubal factor infertility, diminished ovarian reserve/advanced maternal age, male factor infertility, and other/unknown. We compared self-reported measures from 2018 to self-reported and clinical data from prior study initiation, using Cohen’s kappa, sensitivity, specificity, and 95% confidence intervals. Results: Of 2644 women we attempted to recontact, 808 completed the ART-FS, with an average follow-up of 19.6 years (standard deviation: 2.7). Recall of fertility treatment usage had moderate sensitivity (IVF = 0.85, Clomiphene/Gonadotropin = 0.81) but low specificity across different infertility treatment modalities (IVF = 0.63, Clomiphene/Gonadotropin = 0.55). Specific IVF details had low to moderate validity and reliability with clinical records. Reliability of recalled infertility diagnosis was higher when compared to self-report at ART initiation (PCOS K = 0.66, Endometriosis K = 0.76, Tubal K = 0.73) than when compared to clinical records (PCOS K = 0.31, Endometriosis K = 0.48, Tubal K = 0.62) and varied by diagnosis. Conclusions: The ability of women to recall specific IVF treatment details was moderately accurate and recall of self-reported infertility diagnosis varied by diagnosis and measurement method.
- 12 March 2021
- Published by Springer Nature in Fertility Research and Practice
- Vol. 7 (1) , 1-13
Open AccessSelf-reported infertility diagnoses and treatment history approximately 20 years after fertility treatment initiation
Background: Infertility history may have important implications for clinical practice and scientific discovery. Previous research on the validity of self-reported infertility measurements has been limited in scope and duration (< 5 years). In this study, we validated self-reported infertility history measures 15–23 years after fertility treatment initiation among women who utilized assisted reproductive technology (ART). Methods: Women who received ART treatments from three Boston infertility clinics and who enrolled in a prior study (1994–2003) were re-contacted in 2018 for the AfteR Treatment Follow-up Study (ART-FS). Infertility history was collected from clinical records and two self-report questionnaires (at ART initiation and at ART-FS enrollment). Treatment history included specific details (fresh or frozen embryo transfers, number of cycles) and treatment recall prior to ART initiation. Self-reported infertility diagnoses included polycystic ovary syndrome (PCOS), endometriosis, uterine factor infertility, tubal factor infertility, diminished ovarian reserve/advanced maternal age, male factor infertility, and other/unknown. We compared self-reported measures from 2018 to self-reported and clinical data from prior study initiation, using Cohen’s kappa, sensitivity, specificity, and 95% confidence intervals. Results: Of 2644 women we attempted to recontact, 808 completed the ART-FS, with an average follow-up of 19.6 years (standard deviation: 2.7). Recall of fertility treatment usage had moderate sensitivity (IVF = 0.85, Clomiphene/Gonadotropin = 0.81) but low specificity across different infertility treatment modalities (IVF = 0.63, Clomiphene/Gonadotropin = 0.55). Specific IVF details had low to moderate validity and reliability with clinical records. Reliability of recalled infertility diagnosis was higher when compared to self-report at ART initiation (PCOS K = 0.66, Endometriosis K = 0.76, Tubal K = 0.73) than when compared to clinical records (PCOS K = 0.31, Endometriosis K = 0.48, Tubal K = 0.62) and varied by diagnosis. Conclusions: The ability of women to recall specific IVF treatment details was moderately accurate and recall of self-reported infertility diagnosis varied by diagnosis and measurement method.
- 1 December 2020
- Published by Elsevier in Fertility and Sterility
- Vol. 114 (6) , 1169-1170
Too much of a good thing? Total gonadotropin dose and in vitro fertilization outcomes
- 1 December 2020
- Published by Elsevier in Fertility and Sterility
- Vol. 114 (6) , 1169-1170
Too much of a good thing? Total gonadotropin dose and in vitro fertilization outcomes
- 1 April 2020
- Published by Elsevier in Fertility and Sterility
- Vol. 113 (4) , 753-754
Beware a web of associations: endometrial thickness and small for gestational age babies
- 1 April 2020
- Published by Elsevier in Fertility and Sterility
- Vol. 113 (4) , 753-754
Beware a web of associations: endometrial thickness and small for gestational age babies
- 1 September 2012
- Published by Elsevier in Fertility and Sterility
- Vol. 98 (3) , 735-740.e5
Population-based study of attitudes toward posthumous reproduction
- 1 September 2012
- Published by Elsevier in Fertility and Sterility
- Vol. 98 (3) , 735-740.e5
Population-based study of attitudes toward posthumous reproduction